Indacaterol, A Novel Once Daily Inhaled β2-Adrenoreceptor Agonist
The Open Respiratory Medicine Journal
•
12 Mar 2009 •
RESEARCH ARTICLE
•
DOI: 10.2174/1874306400903010027
Abstract
In this article we will review the role of long acting β2-adrenoreceptor agonists and long-acting muscarinic agents in the management of airflow obstruction. We will then focus our attention on indacaterol, one of the new once daily inhaled β2-adrenoreceptor agonists. Pharmacologically this drug is a nearly full β2-agonist without loss of efficacy after prolonged administration. We will also discuss its dosing, safety and tolerability.
Keywords: Indacaterol, tachyphylaxis, activity profile, safety..
